What is the primary cause of postoperative death after primary retroperitoneal sarcoma surgery in a high-volume center? A nationwide study by the French Sarcoma Group
Maud Neuberg(Institut Gustave Roussy), Charles Honoré(Institut Gustave Roussy), Frédéric Marchal(Institut de Cancérologie de Lorraine), Romuald Wernert(Institut de Cancérologie de l'Ouest), Matthieu Faron(Institut Gustave Roussy), M. Fau(Biocodex (France)), Sharmini Varatharajah(Centre François Baclesse), Gauthier Decanter(Centre Oscar Lambret), Sylvie Bonvalot(Dana-Farber Cancer Institute), Sylvain Causeret(Champalimaud Foundation), Pierre Méeus(Centre Léon Bérard), Sébastien Carrère, Jean‐Baptiste Delhorme(Hôpitaux Universitaires de Strasbourg), A. Bouillin(Institut de Recherche en Cancérologie de Montpellier), Dimitri Tzanis(Université Paris Cité)
Cited by 1
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k